Gene silencing of β-catenin by RNAi inhibits cell proliferation in human esophageal cancer cells in vitro and in nude mice

Diseases of the Esophagus

Volumn 22, Issue 2, 2009, Pages 151-162

  Wang, Jin Sheng ^a,b   Zheng, Chang Li ^b   Wang, Yong Jin ^b   Wen, Ji Fang ^a   Ren, Hong Zheng ^a   Liu, Ying ^a   Jiang, Hai Ying ^a  

^a Central South University   (China)

^b CHANGZHI MEDICAL COLLEGE   (China)

Author keywords

catenin; Cyclin D1; Esophageal squamous cell carcinoma; RNA interference

Indexed keywords

BETA CATENIN; CASPASE; CYCLIN D1; SHORT HAIRPIN RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CARCINOMA CELL; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; ESOPHAGUS CARCINOMA; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PLASMID; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR XENOGRAFT; WESTERN BLOTTING;

ANIMALS; BETA CATENIN; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN D1; G0 PHASE; G1 PHASE; HUMANS; MICE; MICE, NUDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 60549097083     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2008.00875.x     Document Type: Article

References (36)

1. Lu S H. Alterations of oncogenes and tumor suppressor genes in esophageal cancer in China. Mutat Res 2000; 462: 343-53.
2. McCabe M L, Dlamini Z. The molecular mechanisms of oesophageal cancer. Int Immunopharmacol 2005; 5: 1113-30.
3. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics. 2007. CA Cancer J Clin 2007; 57: 43-66.
4. Peifer M, Polakis P. Wnt signaling in oncogenesis and embryogenesis - a look outside the nucleus. Science 2000; 287: 1606-9.
5. Polakis P. The many ways of Wnt in cancer. Curr Opin Genet Dev 2007; 17: 45-51.
6. Kimura Y, Shiozaki H, Doki Y, Yamamoto M, Utsunomiya T, Kawanishi K etal. Cytoplasmic beta-catenin in esophageal cancers. Int J Cancer 1999; 84: 174-8.
7. de Castro J, Gamallo C, Palacios J, Moreno-Bueno G, Rodríguez N, Feliu J, González-Barón M. Beta-catenin expression pattern in primary oesophageal squamous cell carcinoma. Relationship with clinicopathologic features and clinical outcome. Virchows Arch 2000; 437: 599-604.
8. Zhou X B, Lu N, Zhang W, Quan LP, Lin DM, Wang QH, Li Y L etal. Expression and significance of beta-catenin in esophageal carcinoma. Ai Zheng 2002; 21: 877-80.
9. Sanders D S, Bruton R, Darnton S J, Casson A G, Hanson I, Williams H K, Jankowski J. Sequential changes in cadherin-catenin expression associated with the progression and heterogeneity of primary oesophageal squamous carcinoma. Int J Cancer 1998; 79: 573-9.
10. Saeki H, Tanaka S, Sugimachi K, Kimura Y, Miyazaki M, Ohga T, Sugimachi K. Interrelation between expression of matrix metalloproteinase 7 and beta-catenin in esophageal cancer. Dig Dis Sci 2002; 47: 2738-42.
11. Ninomiya I, Endo Y, Fushida S, Sasagawa T, Miyashita T, Fujimura T, Nishimura G etal. Alteration of beta-catenin expression in esophageal squamous-cell carcinoma. Int J Cancer 2000; 85: 757-61.
12. Mann B, Gelos M, Siedow A, Hanski ML, Gratchev A, Ilyas M, Bodmer W F etal. Target genes of beta-catenin-T cell-factor/ lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc Natl Acad Sci USA 1999; 96: 1603-8.
13. He T C, Sparks A B, Rago C, Hermeking H, Zawel L, da Costa L T, Morin P J et al. Identification of c-MYC as a target of the APC pathway. Science 1998; 281: 1509-12.
14. Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999; 398: 422-6.
15. Toloza E M, D'Amico T A. Targeted therapy for non-small cell lung cancer. Semin Thorac Cardiovasc Surg 2005; 17: 199-204.
16. Agami R. RNAi and related mechanisms and their potential use for therapy. Curr Opin Chem Biol 2002; 6: 829-34.
17. Yokoyama K, Kamata N, Hayashi E, Hoteiya T, Ueda N, Fujimoto R, Nagayama M. Reverse correlation of E-cadherin and snail expression in oral squamous cell carcinoma cells in vitro. Oral Oncol 2001; 37: 65-71.
18. Yamamoto H, Ochiya T, Takeshita F, Toriyama-Baba H, Hirai K, Sasaki H, Sasaki H etal. Enhanced skin carcinogenesis in cyclin D1-conditional transgenic mice: Cyclin D1 alters keratinocyte response to calcium-induced terminal differentiation. Cancer Res 2002; 62: 1641-7.
19. Ma G, Yang C, Qu Y, Wei H, Zhang T, Zhang N. The flavonoid component isorhamnetin in vitro inhibits proliferation and induces apoptosis in Eca-109 cells. Chem Biol Interact 2007; 167: 153-60.
20. De Cesare M, Perego P, Righetti S C, Pratesi G, Carenini N, Rivoltini L, Zupi G et al. Enhanced antitumour efficacy of gimatecan in combination with Bcl-2 antisense oligonucleotide in human melanoma xenografts. Eur J Cancer 2005; 41: 1213-22.
21. Korinek V, Barker N, Morin P J, van Wichen D, de Weger R, Kinzler K W, Vogelstein B etal. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 1997; 275: 1784-7.
22. Polakis P. Wnt signaling and cancer. Genes Dev 2000; 14: 1837-51.
23. Zhu A J, Watt F M. Beta-catenin signalling modulates proliferative potential of human epidermal keratinocytes independently of intercellular adhesion. Development 1999; 126: 2285-98.
24. Yamamoto H, Vinitketkumnuen A, Adachi Y, Taniguchi H, Hirata T, Miyamoto N, Nosho K et al. Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma. Carcinogenesis 2004; 25: 2353-60.
25. Verma U N, Surabhi R M, Schmaltieg A, Becerra C, Gaynor RB. Small interfering RNAs directed against beta-catenin inhibit the in vitro and in vivo growth of colon cancer cells. Clin Cancer Res 2003; 9: 1291-300.
26. Bertrand J R, Pottier M, Vekris A, Opolon P, Maksimenko A, Malvy C. Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo. Biochem Biophys Res Commun 2002; 296: 1000-4.
27. Miyagishi M, Hayashi M, Taira K. Comparison of the suppressive effects of antisense oligonucleotides and siRNAs directed against the same targets in mammalian cells. Antisense Nucleic Acid Drug Dev 2003; 13: 1-7.
28. Nagy P, Arndt-Jovin D J, Jovin T M. Small interfering RNAs suppress the expression of endogenous and GFP-fused epidermal growth factor receptor (erbB1) and induce apoptosis in erbB1-overexpressing cells. Exp Cell Res 2003; 285: 39-49.
29. Huang W S, Wang J P, Wang T, Fang J Y, Lan P, Ma J P. ShRNA-mediated gene silencing of beta-catenin inhibits growth of human colon cancer cells. World J Gastroenterol 2007; 13: 6581-7.
30. Veeramachaneni N K, Kubokura H, Lin L, Pippin J A, Patterson G A, Drebin J A, Battafarano R J. Down-regulation of beta catenin inhibits the growth of esophageal carcinoma cells. J Thorac Cardiovasc Surg 2004; 127: 92-8.
31. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R, Ben-Ze'ev A. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 1999; 96: 5522-7.
32. Coqueret O. Linking cyclins to transcriptional control. Gene 2002; 299: 35-55.
33. Takahashi Y, Kawate S, Watanabe M, Fukushima J, Mori S, Fukusato T. Amplification of c-myc and cyclin D1 genes in primary and metastatic carcinomas of the liver. Pathol Int 2007; 57: 437-42.
34. Shiina H, Igawa M, Shigeno K, Terashima M, Deguchi M, Yamanaka M, Ribeiro-Filho L et al. Beta-catenin mutations correlate with over expression of C-myc and cyclin D1 genes in bladder cancer. J Urol 2002; 168: 2220-6.
35. Research Committee on Malignancy of Esophageal Cancer, Japanese Society for Esophageal Disease. Prognostic significance of cyclin D1 and E-cadherin in patients with esophageal squamous cell carcinoma: multiinstitutional retrospective analysis. J Am Coll Surg 2001; 192: 708-18.
36. Itami A, Shimada Y, Watanabe G, Imamura M. Prognostic value of p27 (Kip1) and cyclin D1 expression in esophageal cancer. Oncology 1999; 57: 311-7.